Tirzepatide, like Semaglutide, aids weight loss by boosting Leptin, a satiety hormone, promoting fullness. It mimics glucagon-like peptide-1 (GLP-1) to regulate appetite, insulin, and blood sugar imbalances, common hurdles in weight loss.
Research indicates that individuals utilizing tirzepatide experienced an average weight loss of 22.5% over a 72-week duration,
surpassing the weight loss observed with any other GLP-1 agonist. (https://www.nejm.org/doi/full/10.1056/NEJMoa2206038)
Beyond weight loss, it enhances A1C levels, lowering blood pressure and cholesterol, reducing heart disease risk.
How Does Tirzepatide Work?
- Delays how quickly our stomachs digest food, leading to a feeling of fullness and satisfaction with smaller meal sizes.
- Slows intestinal motility so you will feel fuller longer after meals.
- Dual action receptors allow for lower blood sugars, in part by reducing the production of sugar in the liver.
- Stimulates insulin secretion by the pancreas.
- GIP increases energy expenditure, resulting in weight loss reductions.
Contraindications: history of pancreatitis, Type 1 diabetes, alcoholism, multiple endocrine neoplasia type 2 medullary thyroid cancer.
Potential side effects: minimal and dose-dependent nausea, diarrhea, constipation, vomiting, indigestion, headache, and fatigue, with lower risks compared to Semaglutide.
Medications can be conveniently shipped to our office or your home, and assistance is available for your first injection if needed.